Neutralizing monoclonal antibody in patients with coronavirus disease 2019: an observational study
{{output}}
Background: Clinical data on patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant are limited, especially on clinical status after the application of antibody therapy. ... ...
